Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Hunho Jo
Introduction
Hunho Jo is a prominent inventor based in Busan, South Korea. He has made significant strides in the field of biotechnology, particularly in the development of diagnostic tools for prostate cancer. His work is characterized by a commitment to enhancing diagnostic accuracy and early detection methods.
Latest Patents
Hunho Jo holds a patent for a DNA aptamer specifically binding to EN2 (Engrailed-2). This invention relates to a biosensor designed for diagnosing prostate cancer. The DNA aptamer demonstrates a strong binding force and excellent specificity towards EN2 proteins. This innovation addresses the detection specificity issues associated with the prostate-specific antigen (PSA) test, which is commonly used for prostate cancer diagnosis. The potential applications of this invention are expected to significantly improve early diagnosis and increase the accuracy of prostate cancer diagnostics.
Career Highlights
Hunho Jo is affiliated with the Postech Academy-Industry Foundation, where he continues to contribute to research and development in biotechnology. His work has garnered attention for its practical applications in medical diagnostics, particularly in oncology.
Collaborations
Hunho Jo has collaborated with notable colleagues, including Changill Ban and Yoon-Keun Kim. These partnerships have facilitated advancements in his research and have contributed to the successful development of his patented technologies.
Conclusion
Hunho Jo's innovative contributions to the field of biotechnology, particularly in prostate cancer diagnostics, highlight the importance of research and development in improving medical outcomes. His work exemplifies the potential of targeted therapies and diagnostic tools in enhancing patient care.